ETTX
Income statement / Annual
Last year (2021), Entasis Therapeutics Holdings Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2021, Entasis Therapeutics Holdings Inc.'s net income was -$47.14 M.
See Entasis Therapeutics Holdings Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00 |
$0.00 |
$7.00 M |
$5.00 M |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
$0.00
|
$7.00 M
|
$5.00 M
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
1
|
1
|
0
|
0
|
| Research and Development Expenses |
$37.11 M
|
$41.02 M
|
$40.17 M
|
$33.05 M
|
$25.75 M
|
$15.78 M
|
| General & Administrative Expenses |
$15.21 M
|
$13.21 M
|
$13.77 M
|
$10.16 M
|
$5.60 M
|
$3.33 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$15.21 M
|
$13.21 M
|
$13.77 M
|
$10.16 M
|
$5.60 M
|
$3.33 M
|
| Other Expenses |
$0.00
|
-$3.56 M
|
-$2.30 M
|
-$5.34 M
|
$0.00
|
$0.00
|
| Operating Expenses |
$52.32 M
|
$50.67 M
|
$51.64 M
|
$37.87 M
|
$31.34 M
|
$19.10 M
|
| Cost And Expenses |
$52.32 M
|
$50.67 M
|
$51.64 M
|
$37.87 M
|
$29.95 M
|
$19.10 M
|
| Interest Income |
$13.00 K
|
$173.00 K
|
$1.46 M
|
$390.00 K
|
$25.00 K
|
$9.00 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$104.00 K
|
$141.00 K
|
$142.00 K
|
$164.00 K
|
$194.00 K
|
$177.00 K
|
| EBITDA |
-$47.04 M |
-$50.36 M |
-$43.03 M |
-$32.32 M |
-$29.73 M |
-$18.92 M |
| EBITDA Ratio |
0
|
0
|
-6.15
|
-6.46
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
-6.71
|
-7.64
|
0
|
0
|
| Total Other Income/Expenses Net |
$0.00
|
$3.74 M
|
$3.76 M
|
$5.73 M
|
$1.42 M
|
$9.00 K
|
| Income Before Tax |
-$47.14 M
|
-$50.50 M
|
-$43.17 M
|
-$32.48 M
|
-$29.92 M
|
-$19.10 M
|
| Income Before Tax Ratio |
0
|
0
|
-6.17
|
-6.5
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$677.00 K
|
$472.00 K
|
$0.00
|
$9.00 K
|
| Net Income |
-$47.14 M
|
-$50.50 M
|
-$43.85 M
|
-$32.95 M
|
-$29.92 M
|
-$19.10 M
|
| Net Income Ratio |
0
|
0
|
-6.26
|
-6.59
|
0
|
0
|
| EPS |
-1 |
-2.1 |
-3.33 |
-9.64 |
-8.05 |
-5.14 |
| EPS Diluted |
-1 |
-2.1 |
-3.33 |
-9.64 |
-8.05 |
-5.14 |
| Weighted Average Shares Out |
$47.31 M
|
$24.06 M
|
$13.16 M
|
$3.42 M
|
$3.72 M
|
$3.72 M
|
| Weighted Average Shares Out Diluted |
$47.31 M
|
$24.06 M
|
$13.16 M
|
$3.42 M
|
$3.72 M
|
$3.72 M
|
| Link |
|
|
|
|
|
|
